We speak to Chris Albertyn, a researcher who is using medical marijuana to treat dementia patients in one of the first major trials. Watch more discussions from our Being Patient: Brain Talks series here:
To catch our Brain Talks with experts live, join our Facebook page:
For the latest news on dementia research and lifestyle tips, visit our site:
Our mission is to give people impacted by dementia a better resource and connection to experts at the forefront of research. Our founder Deborah Kan funded Being Patient solely with her own savings to understand if people would value such a resource. Our audience has grown so rapidly, we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient’s editorial costs. We employ a team of journalists to give you the best possible information on dementia and brain health without bias.
If you would like to contribute, you can do so by clicking the following link: